AstraZeneca is still waiting for the go-ahead from the U.S. drug regulator to restart the clinical trial of its potential COVID-19 vaccine in the United States, Chief Executive Pascal Soriot…

Read more »

The post AstraZeneca Still Waiting for FDA Decision to Resume U.S. Trial appeared first on Hamodia.

In related news:

  1. White House Adviser Won’t Rule Out More Money for States, Small Businesses
  2. From Houston to New York, America’s Municipal Finances Are in Tatters
  3. Transit Systems Face Plunging Ridership Amid Virus Fears
  4. Trump Pick to Oversee Rescue Spending Pledges Impartiality
  5. Azar Says Vaccine Is Not a Race, Doubts Russia